<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Anne Staylor

Former Senior Editor, Medtech Insight. +25 years in various leadership roles in business intelligence, marketing, communications, product management, and consulting for medical device industry, hospitals, physician groups, insurers. Registered nurse and former Director of Marketing for a national ambulatory surgery company.

Neuro Therapies

Terumo Neuro: Aiming for #1 in Neurovascular

Carsten Schroeder, president and CEO of Terumo Neuro, discusses the company’s plans to capture share and...

Neuro Therapies

Q'Apel Medical: Differentiating Devices for Neurointervention

Q’Apel Medical CEO Jodie Fam discusses the company, strategies for growth and Q’Apel’s approach to innov...

Neuro Therapies

ESMINT 2024: What's New in Neurointervention

SmartTRAK reports on the latest research and innovation in neurointervention from ESMINT 2024. The Europ...

Neuro Therapies

ASPN 2024: Research and Innovation in Interventional Pain

SmartTRAK reports the latest research and innovation in interventional pain management from ASPN 2024. I...

Neuro Therapies

Medtronic: Transforming DBS Therapy - An Interview with Amaza Reitmeier

Amaza Reitmeier, Medtronic’s VP and GM of Brain Modulation, discusses the company’s recent FDA approvals...

Neuro Therapies

SNIS 2024: An Interview with Imperative Care's Ariel Sutton

Ariel Sutton, EVP and GM of Imperative Care’s Stroke business, discusses the Imperative Trial, the compa...

Neuro Therapies

ASPN 2024: SmartTRAK's Interview with Tim Deer, MD

ASPN Chairman Tim Deer, MD, discusses the research and innovation at ASPN 2024 and the society’s collabo...

Neuro Therapies

INS 2024: The Past, Present and Future of Neuromodulation

INS President Dr. Marc Russo and INS President-Elect Dr. Konstantin Slavin discuss the current “state of...

Neuro Therapies

Inceptiv SCS: Offering Options in a Closed-Loop Device

Medtronic’s David Carr, VP & GM, Pain Interventions, discusses Inceptiv closed-loop SCS in an interv...

Neurovascular

Route 92 Medical: Raising the Bar in Neurovascular Thrombectomy

Adam Hattan, VP of marketing for Route 92 Medical, discusses the SUMMIT MAX trial and provides an update...

1 2 3 4 5
...
12